Combination Treatment of Polo-Like Kinase 1 and Tankyrase-1 Inhibitors Enhances Anticancer Effect in Triple-negative Breast Cancer Cells - Concepedia

Concepedia

Publication | Open Access

Combination Treatment of Polo-Like Kinase 1 and Tankyrase-1 Inhibitors Enhances Anticancer Effect in Triple-negative Breast Cancer Cells

DOI Full Paper Access

21

Citations

14

References

2018

Year

Geun‐Hyoung Ha, Dongyoung Kim, Eun‐Kyoung Breuer, Chung Kwon Kim

Anticancer Research

Abstract

Combination therapy of PLK1 and TNKS1 inhibitors may improve the therapeutic efficacy of the current treatment for TNBC.

References

	Year	Citations

Page 1